Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis
Clinical trial NCT03691909 · COMPLETED
Trial details
- NCT number
- NCT03691909
- Sponsor
- Hope Biosciences LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-25
- Primary completion
- 2020-08-17
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.